Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (SRPT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.8B; returns 1 day -2.5%, 1 week +3.7%, 1 year -19.0%.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on engineering precision genetic medicines for rare, devastating diseases. The company is a market leader in Duchenne muscular dystrophy (DMD). Its revenue is generated from product sales, which for the full-year 2025 were preliminarily reported at $1.86 billion.

Groups SRPT belongs to

• Shrinking Share Count
• Biotechnology
• Rare Diseases
• Duchenne Muscular Dystrophy
• Commercial Stage Biotech
• Gene Therapy
• Exon Skipping
• Biopharmaceutical
• Precision Medicine
• Healthcare
• Life Sciences
• Commercial Stage

SRPT financial model: income statement, cash flow and balance sheet